Plasma Cell Leukemia in Relapse
1 clinical trials · Condition
◉ Watch Plasma Cell Leukemia in Relapse
| Record | Firm | Date |
|---|---|---|
| Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT05893693) | Aibin Liang，MD，Ph.D. | 2023-04-12 |
Track Plasma Cell Leukemia in Relapse automatically
Every clearance here is in the API, with alerts when new ones post.